LCID
Lucid Group, Inc.
LCID has lower modeled downside risk, despite its lower overall score.
NEGG
Newegg Commerce, Inc.
NEGG has the edge over LCID overall, supported by stronger valuation and stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NEGG Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Strong |
NEGG's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
NEGG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 19x | $8.65 | — |
| Cheap | 61x | $27.55 | +218% |
| Fair | 105x | $47.21 | +446% |
| Expensive | 220x | $98.94 | +1044% |
Historical ranges are pointers, not guarantees.
NEGG's PE is in its cheap range at 19x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NEGG Forward outlook
There aren't enough analyst estimates for NEGG to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
NEGG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.45 | +$1.61 |
| Q1 2026 | $0.23 | +$1.92 |
| Q4 2025 | -$0.25 | +$1.97 |
| Q3 2025 | -$0.71 | +$1.83 |
| Q2 2025 | -$1.16 | +$1.68 |
| Q1 2025 | -$1.69 | +$1.28 |
| Q1 2024 | -$2.97 | +$0.37 |
| Q1 2023 | -$3.34 | -584% |
NEGG has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over NEGG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
NEGG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $320.4M | -8.1% |
| Q1 2026 | $306.2M | -12% |
| Q4 2025 | $374.4M | +21% |
| Q3 2025 | $374.4M | +21% |
| Q2 2025 | $348.5M | +13% |
| Q1 2025 | $347.2M | +12% |
| Q4 2024 | $308.7M | -32% |
| Q3 2024 | $308.7M | -2.8% |
NEGG's revenue is growing: $320M last quarter, down 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.4% | +1.6 points |
| Q1 2026 | 2.4% | +3.4 points |
| Q4 2025 | -0.3% | +3.2 points |
| Q3 2025 | -0.3% | +3.2 points |
| Q2 2025 | -1.2% | +3.7 points |
| Q1 2025 | -1% | +3.8 points |
| Q4 2024 | -3.5% | +0.4 points |
| Q3 2024 | -3.5% | +2.4 points |
NEGG has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
NEGG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $24.9M | +$80.3M |
| Q1 2026 | -$46.3M | -1188% |
| Q4 2025 | $10.8M | -64% |
| Q3 2025 | $10.8M | -64% |
| Q2 2025 | -$55.5M | -$23.3M |
| Q1 2025 | $4.3M | +$36.5M |
| Q4 2024 | $30M | -40% |
| Q3 2024 | $30M | +70% |
NEGG has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NEGG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.2x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -18.3x | Net Cash |
| Q1 2022 | 2.3x | Moderate |
| Q4 2021 | 0.2x | Very low |
| Q3 2021 | -0.8x | Net Cash |
| Q2 2021 | -1.6x | Net Cash |
| Q1 2021 | -1.7x | Net Cash |
NEGG has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NEGG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.5 | Oversold |
| Stochastic | 4.6 | Oversold |
NEGG's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
NEGG PE vs Consumer Cyclical Sector
| Metric | NEGG | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 7.5% above |
| PE % | 0 | 47 | 47 pts below |
NEGG is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
NEGG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 19% below |
| 20 week MA | $13.4 | 36% below |
| 50 week MA | $29.3 | 71% below |
| 100 week MA | $29.7 | 71% below |
| 200 week MA | $24.9 | 65% below |
NEGG is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over NEGG on returns for 2026, with the stronger performance.
NEGG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $64.0 | $94.2 | +47% |
| 2021 | $94.2 | $219.6 | +133% |
| 2022 | $219.6 | $26.4 | -88% |
| 2023 | $26.4 | $25.2 | -4.5% |
| 2024 | $25.2 | $8.89 | -65% |
| 2025 | $8.89 | $53.0 | +496% |
| 2026 YTD | $53.0 | $8.65 | -84% |
NEGG's yearly returns have swung widely, from +496% in 2025 to −88% in 2022. It's down 84% so far in 2026.